Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: Three case reports

M. Nishida, M. Nakamura

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus.

Original languageEnglish
Pages (from-to)41-43
Number of pages3
JournalInternational Clinical Psychopharmacology
Volume19
Issue number1
DOIs
Publication statusPublished - 2004 Jan 1

    Fingerprint

Keywords

  • Diabetes mellitus
  • Obesity
  • Perospirone
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this